Svenska

Redeye: Orexo - Towards a record year

Report this content

Please note that this is a translation of the analysis report which was published on the 11 September 2018. The Court of Appeals for the Federal Circuit took Orexo’s line entirely, ruling the invalidation of patent ‘330 to be erroneous. The ruling has a positive impact on our valuation.

Read more and download the research report: http://bit.ly/2QFZpmF

Start following companies at Redeye to recieve the latest research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/   

Prenumerera